Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
IDJ International (Holdings) Limited is a Hong Kong-based healthcare group specializing in regenerative medicine, precision medicine, and health management. The company operates through its subsidiary, IDJ Biotech, focusing on the development and application of advanced cell therapies, including Natural Killer (NK) cells and Cytokine-Induced Killer (CIK) cells for oncology and other therapeutic areas. IDJ International integrates R&D, clinical application, and health services to provide personalized medical solutions. Their portfolio includes stem cell research and genetic testing services aimed at early disease detection and anti-aging treatments. The company maintains a strong presence in the Greater Bay Area, collaborating with various medical institutions to advance cell-based clinical research.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on IDJ International.